Tim Clackson is the President and CEO of Theseus Pharmaceuticals, a biopharmaceutical company focused on developing pan-variant inhibitor therapies for cancer.
Tim Clackson is the President and CEO of Theseus Pharmaceuticals, a biopharmaceutical company focused on developing pan-variant inhibitor therapies for cancer. He has nominated development candidates THE-630 and THE-349. Clackson also serves on the Board of Directors of Kesmalea Therapeutics.
Full founder directory · Investor directory · Company funding database · Fundraising library